Nirav Thosani

Dr. Nirav Thosani


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Digestive and Liver Disease
Verified
Journal Article
Closed access
MRMoises Ilan Nevah Rubin
Moises Ilan Nevah Rubin
NTNirav Thosani
Nirav Thosani
RTRajasekhar Tanikella
Rajasekhar Tanikella
DWDavid S. Wolf
David S. Wolf
MFMichael B. Fallon
Michael B. Fallon
FLFrank J. Lukens
Frank J. Lukens

11 February 2015 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
TJTanima Jana
Tanima Jana
NTNirav Thosani
Nirav Thosani
MFMichael B. Fallon
Michael B. Fallon
ADAndrew W. Dupont
Andrew W. Dupont
AEAtilla Ertan
Atilla Ertan
Background and study aims: Gastric antral vascular ectasia (GAVE) is a known cause of gastrointestinal bleeding and chronic iron deficiency anemia. Endoscopic therapy with argon plasma coagulation (APC) is widely used for treatment of GAVE, but most patients continue to require repeated blood transfusions and multiple endoscopic procedures (refractory GAVE). We describe our initial experience regarding safety and efficacy of radiofrequency ablation (RFA) therapy in treating patients with refractory GAVE. Patients and methods: We prospectively enrolled seven patients with refractory GAVE who had multiple prior treatments with APC. These patients were treated with RFA (HALO90 ULTRA Ablation Catheter System; Covidien, GI Solutions, Sunnyvale, CA) at Ertan Digestive Disease Center at our tertiary University Hospital. Results: Seven patients underwent a total of 12 RFA procedures for treatment of refractory GAVE. The median number of RFA procedures was 2 (Range, 1 – 3). Average pre- and post-procedural hemoglobin were 9.3 g/dL and 10.16 g/dL, respectively. Five of seven patients (71 %) were transfusion-free after the RFA treatments while two patients continued to require blood transfusions. There were no complications in this series. Conclusion: RFA can be an effective alternative to APC for treatment of GAVE refractory to previous endoscopic therapy. Additional studies are needed to identify which subset of patients will benefit the most with RFA treatment.

1 June 2018 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
NTNirav Thosani
Nirav Thosani
NSNeil R. Sharma
Neil R. Sharma
IRIsaac Raijman
Isaac Raijman
ATAmar J. Thosani
Amar J. Thosani
BKBijun S. Kannadath
Bijun S. Kannadath
SGSushovan Guha
Sushovan Guha

11 January 2015 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SSSaurabh Sethi
Saurabh Sethi
NTNirav Thosani
Nirav Thosani
SBSubhas Banerjee
Subhas Banerjee

1 May 2017 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
PDF file
DGDeepinder Goyal
Deepinder Goyal
PCPutao Cen
Putao Cen
CWCurtis J. Wray
Curtis J. Wray
JRJulie Rowe
Julie Rowe
SGSushovan Guha
Sushovan Guha
NTNirav Thosani
Nirav Thosani

9 November 2014 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SSSaurabh Sethi
Saurabh Sethi
RKRajan Kochar
Rajan Kochar
SKShivangi T. Kothari
Shivangi T. Kothari
NTNirav Thosani
Nirav Thosani
SBSubhas Banerjee
Subhas Banerjee